Elzonris
tagraxofusp
Listed by Stemline Therapeutics, Inc.
- Strength
- 1000 ug/mL
- Form
- Injection, Solution
- Route
- Intravenous
- Class
- CD123 Interaction; Cytotoxin
What it contains
- Tagraxofusp 1000 ug/mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Drug class | CD123 Interaction; Cytotoxin |
| Approval route | BLA — biologic licence |
| NDC code | 72187-0401 |
| FDA application | BLA761116 |
| RxNorm concept | 2109059 |
| Package sizes listed | 1 |
| Marketed since | January 2019 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.